Lupin Settles Antibiotic Patent Dispute With Medicis
This article was originally published in PharmAsia News
Executive Summary
India's Lupin said it has settled a patent dispute with U.S.-based Medicis Pharmaceutical, the agreement including a research-and-development arrangement